elevance hcsc cigna medicare advantage unit

Elevance, HCSC interested in Cigna’s Medicare Advantage unit

Written by
Written on Dec 15, 2023
Reading time 2 minutes
  • Bloomberg report values Cigna's Medicare Advantage unit at over $3 billion.
  • Cigna reportedly scrapped plans of a merger with Humana Inc this week.
  • Shares of the managed healthcare company are down 3.0% on Friday.

Elevance Health Inc (NYSE: ELV) and Health Care Services Corp (NASDAQ: HCSG) are reportedly interested in buying the Medicare Advantage unit of Cigna Group (NYSE: CI).

Here’s what we know so far

Copy link to section

The said business is worth over $3.0 billion, as per a Bloomberg report on Friday.

Cigna is expected to receive final bids for its Medicare Advantage business in the coming week. But there’s no guarantee that discussions will indeed lead to a sale, as per people familiar with the matter.

Note that the insurance company was reported interested in a merger with peer Humana Inc last month. But the healthcare giants scrapped that plan this week after failing to agree on financial terms of the potential agreement as Invezz reported here.  

Cigna stock is down 3.0% at writing on Friday.

Cigna expects its Medicare unit to lose money

Copy link to section

Cigna was first reported considering a sale of its Medicare Advantage business in November. The unit has less than 600,000 enrolees and is expected to lose money not just this year but in 2024 as well.

The managed healthcare company, after abandoning the prospect of a merger with Humana, revealed plans of repurchasing another $10 billion worth of its stock. At least half of it will be executed in the first six months of 2024, as per Cigna Group.

Last month, the New York listed firm reported solid results for its third financial quarter and raised its outlook for the future.

Wall Street currently has a consensus “overweight” rating on shares of Cigna Group.